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1. Introduction 
The plant kingdom has formed the basis of folk medicine for thousands of years and 
nowadays continues to provide an important source to discover new biologically active 
compounds (Fabricant & Farnsworth, 2001; Gurib-Fakim, 2006; Newman, 2008). The research, 
development and use of natural products as therapeutic agents, especially those derived from 
higher plants, have been increasing in recent years (Gurib-Fakim, 2006). Several lead 
metabolites such as vincristine, vinblastine, taxol and morphine have been isolated from 
plants, and many of them have been modified to yield better analogues for activity, low 
toxicity or better solubility. However, despite the success of this drug discovery strategy, only 
a small percentage of plants have been phytochemically investigated and studied for their 
medicinal potential (Ambrosio et al., 2006; Hostettmann et al., 1997; Soejarto, 1996).  
The first step in the search of new plant-based drugs or lead compounds is the isolation of 
the secondary metabolites. In the past, the natural products researchers were more 
concerned with establishing the structures and stereochemistry of such compounds but, in 
recent years, a great number of studies have concentrated efforts on their biological 
activities (Ambrosio et al., 2006). This multidisciplinary approach was reinforced by the 
substantial progress observed in the development of novel bioassay methods. As a 
consequence, a great number of compounds isolated from plants in the past have been 
“rediscovered” (Ambrosio et al., 2008; Ambrosio et al., 2006; Houghton, 2000; Porto et al., 
2009a; Porto et al., 2009b; Tirapelli et al., 2008). 
Several classes of secondary metabolites are synthesized by plants and, among those, 
lignans are recognized as a class of natural products with a wide spectrum of important 
biological activities. Table 1 summarizes the main biological properties described in the 
literature for lignans.  
The term “Lignan” was first introduced by Haworth (1948) to describe a group of dimeric 
phenylpropanoids where two C6-C3 are attached by its central carbon (C8), as shown in 
Figure 1. More recently, Gotlieb (1978) proposed that micromolecules with two 
phenylpropanoid units coupled in other manners, like C5-C5´ for example should be named 
“neolignans” (Umezawa, 2003). According to Gordaliza et al (2004), lignans can be found in 
more than 60 families of vascular plants and have been isolated from different plant parts, 
exudates and resins. 
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Biological activity Reference 
Antiviral (Charlton, 1998; Cos et al., 2008; McRae & Towers, 1984; 
Yousefzadi et al., 2010) 
Anticancer (McRae & Towers, 1984; Pan et al., 2009; Saleem et al., 
2005; Yousefzadi et al., 2010) 
Cancer prevention (Huang et al., 2010; Webb & McCullough, 2005) 
Anti-inflammatory (Saleem et al., 2005) 
antimicrobial (Saleem et al., 2005) 
antioxidant (Fauré et al., 1990; Pan et al., 2009; Saleem et al., 2005) 
immunosuppressive (Saleem et al., 2005) 
Hepatoprotective (Negi et al., 2008) 
Osteoporosis prevention (Habauzit & Horcajada, 2008) 
Table 1. Main biological activities of lignans 
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Fig. 1. Phenylpropanoid unit and lignan structure 
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Fig. 2. Main subclasses of lignans. Adapted from Suzuki & Umezawa (2007). 
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Most of the known natural lignans are oxidized at C9 and C9´ and, based upon the way in 
which oxygen is incorporated into the skeleton and on the cyclization patterns, a wide range 
of lignans of very different structural types can be formed. Due to this fact, lignans are 
classified in eight subgroups and (Chang et al., 2005; Suzuki & Umezawa, 2007), among 
these subgroups, the furan, dibenzylbutane and dibenzocyclooctadiene lignans can be 
further classified in “lignans with C9 (9´)-oxygen” and “lignans without C9 (9´)-oxygen”. 
Figure 2 displays the main classes of lignans, as well as their subgroups. It is noteworthy 
that, despite its structural variation, lignans also display a substantial variation on its 
enantiomeric composition (Umezawa et al., 1997). In this sense, these metabolites can be 
found as pure enantiomers and as enantiomeric compositions, including racemates (Macias 
et al., 2004). 
2. Chemical aspects of lignans 
As mentioned before, lignins and lignans are both originated from C6-C3 units, thus 
indicating that these metabolites are biosynthesized through the same pathway in the earlier 
steps. As seen in Figure 3, aromatic aminoacids L-phenylalanine and L-tyrosine are 
produced from shikimic acid pathway, and then converted in a series of cinnamic acid  
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Fig. 3. Biosynthesis of hydroxycinamyl alcohol monomers, the precursors of lignans 
according to Dewick (2002). 
www.intechopen.com
 
Phytochemicals – A Global Perspective of Their Role in Nutrition and Health 
 
216 
derivatives. The reduction of these acids via coenzyme A of related esters and aldehydes 
forms three alcohols (p-coumaryl alcohol, coniferyl alcohol and sinalpyl alcohol) that are the 
main precursors of all lignins and lignans. 
The peroxidase induces one-electron oxidation of the phenol group allowing the 
delocalization of the unpaired electron through resonance forms. In these hydroxycinamyl 
alcohols, conjugation allows the unpaired electron to be delocalized also into the side chain. 
After this point, radical pairing of these resonance structures originates reactive dimeric 
systems susceptible to nucleophilic attack from hydroxyl groups, leading to a wide range of 
lignans, as shown in Figure 2.  
Among these subgroups, the biosynthesis of C9 (9´)-oxygen lignans is the most well known. 
This type of lignan is formed through the enantioseletive dimerization of two coniferyl 
alcohol monomeric units (D resonance form of coniferyl alcohol radical, Figure 4) into 
pinoresinol via intermolecular 8,8´ oxidative coupling with the aid of dirigent protein 
(Dewick, 2002; Suzuki & Umezawa, 2007). 
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Fig. 4. Resonance forms of coniferyl alcohol radical 
The following steps involve sequencial stereoselective enzymatic reduction of pinosresinol 
by pinoresinol/lariciresinol reductase to generate lariciresinol and then secoisolariciresinol 
by secoisolariciresinol dehydrogenase. The main steps of this biosynthetic proposal are 
depicted in Figure 5. Secoisolariciresinol gives the presumably common precursor of all 
dibenzylbutyrolactol lignans and, through the formation of matairesinol and yatein, also 
forms the aryltetralin lignans. These subclasses of lignans includes some important bioactive 
compounds such as cubebin (1) and podophyllotoxin (Canel et al., 2000; de Souza et al., 
2005; Gordaliza et al., 2004; Saraiva et al., 2007; Silva et al., 2007; Silva et al., 2009; Srivastava 
et al., 2005; You, 2005; Yousefzadi et al., 2010). 
3. Podophyllotoxin: chemical and biological approaches 
Podophyllotoxin (Figure 6), a naturally occurring aryltetralin lignin, is one of the most 
important compound due to its high toxicity and current use as a local antiviral agent 
(Yousefzadi et al., 2010). Moreover, this metabolite has been used to obtain structural 
analogues which are employed as anticancer drugs (Ayres & Loike, 1990; Yousefzadi et al., 
2010) and several semi-synthetic podophyllotoxin-related derivatives showed to be 
topoisomerase II inhibitor, acting as an antimitotic compound (You, 2005; Yousefzadi et al., 
2010). Figure 6 also shows the clinically valuable anticancer agents, etoposide, teniposide 
and etoposide phosphate, obtained from podophyllotoxin. 
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Fig. 5. Biosynthesis of dibenzylbutyrolactols and aryltetralin lactones (Canel et al., 2000). 
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Fig. 6. Chemical structures of clinically available podophyllotoxin derivatives. 
According to You (2005), podophyllotoxin still can be considered a hot prototype for 
discovery and development of novel anticancer agents, even in the 21st century. This leading 
compound has been isolated from the roots of Podophyllum species and more recently from 
other genus, such as Linum (Yousefzadi et al., 2010). Due to its importance in anticancer 
therapy, several biotechnological approaches including the use of cell cultures, 
biotransformation processes and metabolic engineering techniques to manipulate the 
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biosynthetic pathway (Figure 7), have been currently developed and are alternatives for the 
production of podophyllotoxin. 
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Fig. 7. Biosynthesis proposal of podophyllotoxin according to Canel et al., 2000. 
Despite the fact that etoposide, teniposide and etoposide phosphate are clinically valuable 
anticancer agents, several adverse effects and drug resistance have been associated with the 
use of these drugs (You, 2005). In this sense, several studies focusing to prepare novel 
derivatives and to understand the structure-activity relationship (SAR) of podophyllotoxins 
have been published (You, 2005). Based on these data a great number of potential drug 
candidates were synthesized (You, 2005; Yousefzadi et al., 2010). Figure 8 shows the 
structures of new antineoplasic candidates developed from podophyllotoxin chemical 
skeleton. 
In order to better explore the biological potential of this class of metabolites, our research 
group has concentrated efforts to investigate the biological activity of some 
dibenzylbutyrolactone lignans, mainly cubebin (Figure 9, 1) and its semi-synthetic derivatives. 
In this sense, the most significant achievements in our investigations are described in the 
following sections. 
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Fig. 8. Examples of antineoplasic candidates developed from podophyllotoxin chemical 
skeleton. 
4. Trypanocidal activity of cubebin and its derivatives 
The Chagas’ disease, or American trypanosomiasis, is endemic in Central and South 
America and it is estimated that 16–18 million people are currently infected with the 
protozoan flagellate Trypanosoma cruzi (Molfetta et al., 2005) and more than 100 million are 
exposed to the risk of infection (Takeara et al., 2003). 
Since it was discovery in 1909, Chagas´ disease infection has been difficult to control due to 
its multiple characteristics (de Souza et al., 2005). One of the main causes of these difficulties 
are to find an efficient compound to combat the aetiologic agent (T. cruzi) is directly linked 
to the morphologic characteristics of its strains, mainly due to the occurrence of various sub-
populations of the parasite, leading to a different host tissue´s tropism (de Souza et al., 
2005).  
Clinical treatment of infected patients is relied on two nitroheterocyclic drugs, the nifrofuran 
nifurtimox, Lampit®, which production has now been discontinued, and the 2-
nitroimidazole benznidazole, Rochagan® (Paulino et al., 2005). Both drugs, if administered 
during the acute phase of the disease, could cure 50-70% of the patients. However, these 
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drugs display limited efficacy in the treatment of the chronic phase of the disease and are 
quite toxic for the patients (de Souza et al., 2005). Therefore, there is an urgent demand for 
the discovery and development of novel therapeutic compounds to treat Chagas´ disease 
De Souza et al. (2005) (de Souza et al., 2005) have reported the trypanocidal activity of 
cubebin (1) and its semi-synthetic derivatives against free amastigote forms of T. cruzi. 
Figure 9 also shows the compounds obtained by partial synthesis from cubebin (1), as well 
as the reagents and conditions used in these reactions.  
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Fig. 9. Reagents and conditions: (a) Ac2O, Py, room temperature, 24 h; (b) NaH, BnBr, THF, 
room temperature, 24h; (c) EtONa, (CH3)2CH2Cl, EtOH, reflux, 6h; (d) PCC, CH2Cl2, room 
temperature, 12h; (e) HNO3, 2h, -10° C. 
The natural cubebin (1), used as the starting compound to obtain the evaluated 
dibenzylbutyrolactone derivatives, did not display activity against trypomastigote forms of 
T. cruzi (Bastos et al., 1999). Hence, the biological evaluation against amastigote forms was 
undertaken only for lignans 2, 3, 4, 5 and 6. Cubebin was selected as starting compound 
because of its availability, being easily isolated in large amounts from the seeds of Piper 
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cubeba (de Souza et al., 2005). Table 2 shows the results of the trypanocidal activity 
evaluation of compounds 2, 3, 4, 5, 6 and benznidazole, against amastigote forms of Y strain 
of T. cruzi. 
 
Compounds 
Concentration (μM) X % of lyse (± SD) 
IC50 (μM) 
0.5 2.0 8.0 32.0 
2 14.5 ± 1.9 26.0 ± 2.5 29.0 ± 5.2 26.4 ± 1.2 1.5 X 104 
3 37.0 ± 1.4 38.0 ± 7.0 46.8 ± 6.4 68.8 ± 2.9 5.7 
4 32.6 ± 2.6 55.4 ± 4.3 50.8 ± 1.0 57.8 ± 8.0 4.7 
5 47.6 ± 9.5 57.0 ± 1.1 57.6 ± 8.9 63.6 ± 5.2 0.7 
6 34.6 ± 7.9 48.7 ± 1.4 38.9 ± 2.0 48.5 ± 6.1 95.3 
Benznidazole 38.4 ± 3.0 67.0 ± 7.2 69.0 ± 4.0 68.6 ± 1.7 0.8 
Table 2. Results of the trypanocidal activity evaluation of compounds 2, 3, 4, 5, 6 and 
benznidazole, against amastigote forms of Y strain of T. cruzi (de Souza et al., 2005). 
The production of compound 2 by substitution of the lactol hydrogen of cubebin by an 
acetyl group led to a strong reduction of its trypanocidal ctivity, in comparison with all 
other evaluated compounds belonging to the same group (IC50 = 1.5 X 104 μM; Table 2). 
Furthermore, the comparison of compounds 2 and 3 indicate that the biological activity 
against the amastigote forms of T. cruzi was significantly affected by the nature of the 
substituting group at position C-9, which played an important role in the reduction of the 
calculated IC50 value for compound 3 (IC50 = 5.7 μM; Table 2). Likewise, cubebin derivative 4, 
bearing an amino group at the lactol ring, displayed an activity quite similar to compound 3. 
Analysis of the obtained results, displayed in Table 2, indicate that compound 5 was the 
most active, with an IC50 value of 0.7 μM similar to that displayed by benznidazole (IC50 = 
0.8 μM), a standard drug used as the positive control. On the other hand, most of the other 
evaluated compounds displayed much lower activity, with the exception of compounds 3 
(IC50 = 5.7 μM) and 4 (IC50 = 4.7 μM), which showed significant activity.  
In this study, De Souza et al. (2005) also pointed out that hinokinin (HK, 5) is a promising 
compound to continue examining, since at 0.5 μM it displayed higher activity than 
benznidazole and at the other assayed concentrations (2.0, 8.0 and 32.0 μM) it showed 
similar activity.  
In view of higher trypanocidal activity displayed by HK (5) against free amastigote forms of 
T. cruzi (Table 2; (de Souza et al., 2005), this lignan was selected to be assayed against 
epimastigote and intracellular amastigote forms of T. cruzi, both in vitro and in vivo assays 
(Saraiva et al., 2007). The results of the trypanocidal activity against epimastigote and 
intracellular amastigote forms of T. cruzi are shown in Tables 3 and 4, respectively. 
 
Compounds 
Concentration (μM) X % of lyse (± SD) IC50 
(μM) 0.5 2.0 8.0 32.0 128.0 
HK 21.79±1.82 99.03±0.15 100.0±0.35 100.0±0.35 100.0±0.64 0.67 
Nifurtimox 11.78±13.92 49.38±6.71 65.46±5.36 81.54±2.71 97.54±1.80 3.08 
benznidazole 0 1.23±5.87 26.18±10.71 51.13±5.23 76.09±2.74 30.89 
Table 3. Results of the trypanocidal activity evaluation of HK, benznidazole and nifurtimox 
against epimastigote forms of CL strain of T. cruzi (Saraiva et al., 2007). 
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Compounds 
Concentration (μM) X % of lyse (± SD) 
IC50 (μM) 
2.0 8.0 32.0 128.0 
HK 25.84±1.09 31.92±9.29 61.72±9.17 100.0±0.40 18.36 
Nifurtimox   44.6±0.99 63.78±1.25 83.31±0.79 90.63±1.13 3.54 
benznidazole 14.33±2.65 35.81±0.65 57.28±1.99 78.75±0.67 20.00 
Table 4. Results of the trypanocidal activity evaluation of HK, benznidazole and nifurtimox 
against intracellular amastigote forms of CL strain of T. cruzi (Saraiva et al., 2007). 
As it can be observed in Table 3, HK showed a very significant activity against epimastigote 
forms of T. cruzi, displaying IC50 value (0.67 μM) much lower than benznidazole and 
nifurtimox, used as positive controls (Saraiva et al., 2007). HK, also showed to be very active 
against intracellular amastigote forms, displaying IC50 value of 18.36 μM, which was similar 
to benznidazole (IC50 = 20.0 μM, Table 4).  
The in vivo assays (Saraiva et al., 2007) were performed using five groups of five BALB/c 
males, weighing approximately 20 g each. The groups were as follows: group 1, animals 
without infection; group 2, control infected animals; group 3, animals treated with solvent; 
group 4, animals treated with benznidazole 40 mg kg-1 day-1; group 5, animals treated with 
HK 40 mg kg-1 day-1. The animals were inoculated with 2 X 104 trypomastigote forms of T. 
cruzi (Y strain). The treatment was initiated 48 h after infection and maintained for 20 days. 
The animals were treated twice a day with 20 mg kg-1 benznidazole and HK orally. The 
results obtained showed that the treatment with HK promoted 70.8% of parasitaemia 
reduction in the parasitaemic peak, while benznidazole displayed approximately 29.0% of 
parasite reduction (Saraiva et al., 2007). In addition, HK was able to reduce the number of 
parasites more than benznidazole not only in the parasitaemic peak, but also in all curse of 
infection (Saraiva et al., 2007). 
Moreover, it was observed that the groups treated with HK displayed better survival rates 
than the group treated with benznidazole, with survival until the 22nd and 16th day after the 
beginning of the infection, respectively (Saraiva et al., 2007). Despite the obtained significant 
results for the in vivo assays, the treatment with HK or benznidazole did not cause 
parasitological cure. Overall, considering the promising results displayed by HK against 
both the epimastigote and amastigote forms of the parasite in the in vitro assay, as well as 
the good result displayed in the in vivo assay, this lignan has been considered as a lead 
compound for the development of new drugs for the treatment of Chagas´disease (Saraiva 
et al., 2007). 
In order to obtain better efficacy of HK towards the intracellular forms of the parasite, our 
research group prepared and investigated the effect of HK load poly(D,L-lactide-co-
glycolide) microparticules.  
5. Hinokinin-load poly(d,l-lactide-co-glycolide) microparticles for Chagas´ 
disease 
The drug delivery system were developed for the purposes of bringing, uptaking, retaining, 
releasing, activating, localizing, and targeting the drugs at the right timing, period, dose, 
and place (Ueda & Tabata, 2003). The use of biodegradable polymers, as poly(D,L-lactic-co-
glycolic acid; PLGA), for the controlled release of therapeutic agents is now well established. 
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These systems have been extensively utilized for oral and parenteral administration (Saraiva 
et al., 2010). The physical properties and the Food and Drug Administration approval of 
poly(lactide-co-glycosides) make them the most extensively studied commercially available 
biodegradable polymers (Birnbaum et al., 2000).  
The microparticles can be able to sustain the release of the drug for a considerable period of 
time, to reduce the required frequency of administration increasing patient compliance, to 
avoid plasmatic fluctuations, to decrease side effects, and to facilitate dosage administration 
(Hans & Lowman, 2002). In this sense, our research group prepared HK-loaded PLGA 
microparticles to protect HK of biological interactions and promote its sustained release for 
treatment of Chagas´ disease. Moreover, the trypanocidal effect of microparticles containing 
HK was evaluated in vivo.  
The HK-loaded PLGA microparticles were prepared with success (Saraiva et al., 2010) and 
presented narrow distribution size and a mean diameter of 0.862 μm, with PDI of 0.072 mm. 
Scanning electron micrographs of PLGA microparticles obtained showed that HK loaded 
microparticles presented, smooth and spherical surface. Due to their small diameter, the HK 
microparticles obtained are better suited for parenteral delivery (Cegnar et al., 2005). 
The trypanocidal in vivo experiments were performed using Female Swiss mice (weigh, 20-
22 g) which were infected intraperitoneally with 2 X 104 trypomastigotes forms of T. cruzi. 
The treatment (20 days) was performed through subcutaneous route and initiated 48 h after 
infection, according to Saraiva et al. (2010).  
The treatment of infected mice with 40 mg kg-1 of HK-loaded microparticles each 2 days  
was able to provoke significant decrease in parasitemia levels compared with those 
recorded in untreated controls (P<0.05 at days 12, 14, 16, 19 and 21 post-infection with T. 
cruzi). The treatment with an equivalent amount of empty microparticles (without HK) had 
no effect on the parasitemia compared to untreated controls (Saraiva et al., 2010). Moreover, 
administration of HK-loaded microparticles was able to reduce the number of parasites 
more than  the treatment with 20 mg kg-1 day-1 of HK not only in the parasitemic peak, but 
also in the course  of infection (P<0.05 at days 14, 16, 19 and 21 post-infection with T. cruzi) 
(Saraiva et al., 2010). The use of PLGA micropartiles as vehicle for HK delivery can improve 
HK trypanocidal activity. It may be attributed to the fact that it can protect HK of biological 
interactions and promote its sustained release, with maintenance of its plasmatic 
concentration in therapeutic levels (Saraiva et al., 2010). 
The HK-loaded microparticles developed by our research group can be considerable a 
promising system for sustained release of HK for therapeutic use and could be used in 
future clinical studies (Saraiva et al., 2010). Also, it is very important to point out that other 
in vivo assays have been developed by our research group in order to evaluate the 
parasitological cure of infection and the activity of this delivery system coating HK against 
other strains of T. cruzi. 
6. Influences of stereochemistry on trypanocidal activity of 
dibenzylbutyrolactone lignans 
We have been reporting the significant trypanocidal activity of dibenzylbutyrolactone 
lignans, mainly the semi-synthetic HK.  Such results aroused the interest within our group 
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to study the effect of stereochemistry in this biological property. For this purpose, 
methylpluviatolide, one of the most powerful compounds regarding trypanocidal activity 
(Bastos et al., 1999) was synthesized in its trans and cis racemic forms. Thus, allowing us to 
evaluate the trypanocidal activity not only of a mixture of these two stereoisomers, but also 
of the pure enantiomers, which were separated by chiral HPLC (da Silva et al., 2008). 
Trans (tM) and cis (cM)racemic forms of methylpluviatolide were prepared by a procedure 
described by Landais et al. (1991)  and Charlton and Chee (1997) (Figure 10).  
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Fig. 10. Reagents and conditions: (a) H2, 4 atm, Pd/C, ETOH, HClO4, 60h, room 
temperature; (b) THF, AC2O, Et3N, DMAP, 2h, room temperature; (c) DBU, CH2Cl2, 5h, 
room temperature; (d) H2, 4 atm, Pd/C, ETOH, 60h, room temperature. 
The results obtained for the racemic mixture of trans and cis methylpluviatolide against T. 
cruzi showed that racemic cis-stereoisomer (2) is inactive, while the racemic trans- 
stereoisomer (1) display significant trypanocidal activity, with an IC50 of 89.3 μM (da Silva et 
al., 2008).  
On the basis of these results, a separation of the trans-stereoisomer from the racemic mixture 
was undertaken by chiral HPLC using an analytical Chiracel OJ (4.6 x 250 mm) column, 
aiming to evaluate the trypanocidal activity of each enantiomer separately. The chromatogram 
gave a well resolved peak separation, allowing the isolation of both enantiomers (da Silva et 
al., 2008), which were evaluated against trypomastigote forms of the Y strain of T. cruzi. Table 
5 shows the results of the trypanocidal activity evaluation of (+)-trans- methylpluviatolide 
(+tM) and (-)-trans- methylpluviatolide (-tM) against trypomastigote forms of the Y strain of T. 
cruzi. 
 
Compounds 
Concentration (μM) X % of lyse (± SD)
IC50 (μM) 
 8.0  32.0  128.0 
+tM  5.3±2.5   7.6±3.4   9.9±2.5 1.3 X 106 
-tM 40.6±3.6 52.3±4.4 79.7±0.0 18.7 
Table 5. Results of the trypanocidal activity evaluation of +tM or -tM against 
trypomastigotes forms of the Y strain of T. cruzi. (da Silva et al., 2008). 
The results show that +tM is completely inative, whereas the –tM displayed good activity, 
with an IC50 of 18.7 μM (da Silva et al., 2008). These results indicate that despite being 
completely inactive, the +tM blocks the action of the –tM when they are present in a racemic 
mixture. It should be taken into consideration that the +tM might bind to the active sites as a 
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competitive antagonist, which may be confirmed by comparison of the IC50 value of the 
racemic mixture with that of the –tM itself (da Silva et al., 2008).  
In conclusion, this study pointed the importance of the stereochemistry on trypanocidal 
activity of dibenzylbutyrolactone lignans and brings new perspective in the importance to 
understand the trypanocidal structure-activity relationship for this class of natural compounds. 
7. Antimicrobial potential of some natural and semi-synthetic lignans against 
Mycobacteria and oral pathogens 
The lignans possess a wide spectrum of biological activities, including antimicrobial (Saleem 
et al., 2005). Considering this fact, our research group also decided to investigate the 
potential of some natural and semi-synthetic lignans against mycobateria and oral 
pathogens (Silva et al., 2007; Silva et al., 2009). 
Tuberculosis is a severe infectious disease caused by mycobacteria belonging to the 
Mycobacterium tuberculosis complex. According to WHO, tubercolosis affects nearly 30% of 
the world´s population and is responsible for 3 million deaths worldwide each year, mainly 
in developing countries (Raviglione, 2003). The current chemotherapy of this pathology has 
been based on the use of combined drug therapy with rifampicin, isonizid, and 
pyrazinamide. However, the incorrect use and long drug administration, as well as the high 
cost and countless side-effects have led people to abandon the treatment before being 
completely cured, leading to resistant bacilli (Timmins & Deretic, 2006). In addition, the 
existence of drug-resistant tuberculosis reinforces the need to develop new safe and effective 
antimycobacterial drugs. In this sense, our research group evaluated the antimycobacterial 
activity of several lignans obtained from cubebin (Silva et al., 2009). 
As shown in Figure 11, (-)-cubebin (1) was isolated from powdered seeds of Piper cubeba and 
then submitted to various semi-synthetic procedures to obtain hinokinin (HK, 5), (-)-O-
acetyl-cubebin (2), (-)-O-methyl-cubebin (7), (-)-O-(N,N-dimethylamine-ethyl)-cubebin (4) 
and (-)-6,6´-dinitrohinokinin (6). All these compounds were assayed in vitro by the 
microdilution technique on a Resazurin microtiter assay (REMA) plate, using a procedure 
adapted from (Palomino et al., 2002).  
Cubebin (1) did not display any activity against the investigated strains (Table 6). HK (5) was 
moderately active against Mycobacterium tuberculosis, with a MIC value equal to 62.5 µg mL-1. 
Compound (2), whose lactol group is acetylated, displayed activity against M. tuberculosis 
(MIC = 125 µg mL-1) and M. avium (MIC = 62.5 µg mL-1). The best result was achieved with 
compound 7, whose lactol group is methylated, leading to a MIC value equal to 31.25 µg mL-1 
against M. avium. The other compounds were not active against any of the studied 
mycobacteria. In the case of the lactol-containing compounds evaluated here, it seems to be 
essential that the lactol group is absent, and the substituent of this group should be small, as in 
the case of 2 and 7. M. kansaii (ATCC 12478) was the most resistant mycobacterium concerning 
the evaluated compounds, with MIC values varying between 1000 and 2000 µg mL-1.  
To sum up, cubebin and hinokinin semi-synthetic derivatives were prepared and evaluated 
for their antimycobacterial activity. Some derivatives were active against M. tuberculosis and 
M. avium, suggesting that this class of compounds may lead to a new generation of 
antituberculosis agents (Silva et al, 2009). 
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Fig. 11. Chemical structures and conditions of the reactions (a) Acetic anhydride, room 
temperature, 24h. (b) Dimethyllethylammonium chloride, EtONa, dry THF, room 
temperature, N2 atmosphere, 6h. (c) Methyl iodide, NaH, dry THF, room temperature, 6h. 
(d) PCC (pyridinium chlorochromate) in dry methylene chloride, 24h, in an ice bath with 
continuous stirring. (e) HNO3, chloroform, -6oC, 2h. 
Compound 
MIC [µg mL-1] 
M. tuberculosis M. kansaii M. avium 
1 500 2000 1000 
2 125 1000 62.5 
4 250 2000 250 
5 62.5 2000 500 
6 1000 2000 1000 
7 250 2000 31.25 
Rifampicina 0.031 0.015 0.062 
a Standard antibiotic 
Table 6. Minimal inhibitory concentration (MIC) of cubebin (1) and its derivatives against M. 
tuberculosis, M. kansasii, and M. avium. 
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Recently, our research group also investigated the antimicrobial activity of cubebin and 
related derivatives against oral pathogens, mainly those responsible for caries disease, 
which are intimately related with the dental plaque formation. 
Dental plaque is defined as a biofilm consisting of cariogenic bacteria adhered on the 
tooth surface and plays an important role in the development of dental caries (Chung et 
al., 2006; Xie et al., 2008), one of the main oral diseases that affect humankind (More et al., 
2008; Souza et al., 2010). This destructive infection of the dental hard tissues can progress 
and if untreated, lead to the death of vital pulp tissue and tooth loss (Allaker & Douglas, 
2009). Bacteria from the genus Streptococci are commonly isolated from the oral cavity 
(Hirasawa & Takada, 2002) and have been responsible for this infectious disease. Among 
them, Streptococcus mutans is considered one of the main cariogenic microorganisms, due 
to its ability to synthesize extracellular polysaccharides from sucrose, mainly water-
insoluble glucan, and initiate plaque formation (Koo et al., 2000). Other aerobic bacteria 
such as Enterococcus faecalis, Lactobacillus casei, Streptococcus mitis, S. sanguinis, S. sobrinus 
and S. salivarius are also important in the latter formation of the dental biofilm (Chung et 
al., 2006). 
The mechanical removal of the dental plaque is the most efficient procedure to prevent 
caries, but the majority of the population does not perform this removal efficiently 
(Ambrosio et al., 2008). Moreover, dental treatment is often very expensive and not readily 
accessible, especially in developing countries (More et al., 2008). In this sense, the use of 
chemicals as a complementary measure is necessary and has demonstrated to be of great 
value in the prevention of the formation and in the decreasing of the tooth surface biofilm 
(Furiga et al., 2008). 
Extensive efforts have been made toward the search for anticariogenic compounds that can 
be incorporated into dental products, aiming at complementing the mechanical removal. 
Several antibiotics, such as ampicillin, chlorhexidine, sanguinarine, metronidazole, 
phenolic-antiseptics and quaternary ammonium-antiseptics have been used to prevent 
dental caries. Among these compounds, chlorhexidine is considered a gold standard 
anticariogenic and has received the approval of the American Dental Association Council on 
Dental Therapeutics (Ambrosio et al., 2008). However, the regular use of oral care products 
containing this chemical are often associated with tooth and restoration staining, changes in 
the taste of food, and a burning sensation at the tip of the tongue (Greenberg et al., 2008; 
More et al., 2008; Porto et al., 2009b). In addition, chlorhexidine is much less effective in 
reducing the levels of Lactobacillus species, which are strongly related to caries evolution 
(Ambrosio et al., 2008). All these problems, therefore, denote that finding new, safe and 
effective anticariogenic coumpounds is still needed. 
Thus, our research group tested compounds 1, 4, 5, and 6 (Figure 11) and another semi-
synthetic derivative (O-benzyl cubebin, 8, Figure 12)using the broth microdilution method 
(Andrews, 2001) against the following microorganisms: Enterecoccus faecalis (ATCC 4082), 
Streptococcus salivarius (ATCC 25975), Streptococcus mitis (ATCC 49456), Streptococcus mutans 
(ATCC 25275), Streptococcus sobrinus (ATCC 33478), Streptococcus sanguinis (ATCC 10556) 
and Candida albicans (ATCC 28366) (Silva et al. 2007). Table 7 displays the minimum 
inhibitory concentration values obtained for these compounds 
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Fig. 12. Structure of O-benzyl cubebin (compound 8) 
 
Compound 
Microorganism 
E. 
faecalis 
S. 
salivarius 
S. 
sanguinis 
S. 
mitis 
S. 
mutans 
S. 
sobrinus 
C. 
albicans 
1 0.35 0.25 0.22 0.20 0.32 0.27 0.28 
4 0.31 0.21 0.21 0.19 0.28 0.23 0.23 
5 0.38 0.25 0.25 0.25 0.32 0.28 0.28 
6 0.30 0.20 0.21 0.18 0.27 0.23 0.23 
8 0.31 0.20 0.23 0.18 0.29 0.23 0.28 
CHDa 5.9x10-3 1.7 x10-3 3.9x10-3 5.9x10-3 5.9x10-3 1.5x10-3 7.9x10-3 
a Chlorhexidine 
Table 7. Values of minimum inhibitory concentrations (in milimolar) of cubebin and its 
semi-synthetic derivatives against oral pathogens 
The semi-synthetic derivative 6 was the most active one against all the evaluated 
microorganisms (Table 7). Compounds 5 and 6 are lignan-lactones and differ from cubebin 
by the presence of a carbonyl group at C9 (Figure 11). Analysis of the obtained results 
suggested that the presence of the carbonyl group at C9 with introduction of polar groups in 
the aromatic rings is beneficial for the antimicrobial activity. 
The obtained results for antimicrobial activity are in accordance to those obtained for anti-
inflammatory and analgesic activities. Compounds possessing a lactone ring bearing two 
methylendioxyaryl groups display significant anti-inflammatory and analgesic activities, 
and the introduction of polar groups in the aromatic rings is advantageous for these 
activities . However, with regard to trypanocidal activity, the introduction of nitro groups at 
the aromatic rings is harmful for this activity. Besides, the lignan-lactone HK (5) was the 
most active compound against T. cruzi (de Souza et al., 2005). 
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8. Future perspectives 
Despite of the wide spectrum of biological activities related to lignans, the literature used to 
emphasize the antioxidant properties and the role of these metabolites in cancer treatment 
and prevention. (Fauré et al., 1990; McRae & Towers, 1984; Pan et al., 2009; Saleem et al., 
2005; Yousefzadi et al., 2010). However, in recent years our research group pointed out the 
importance of such metabolites, specially cubebin and their semi-synthetic derivatives, as 
potential antichagasic agents (da Silva et al., 2008; de Souza et al., 2005; Saraiva et al., 2010; 
Saraiva et al., 2007). The very promising results obtained against T. cruzi suggested that 
further investigations of these lignans against other parasitic diseases should be performed. 
In this sense, our group is now focusing the evaluation of such compounds against, for 
example, Schistossoma mansoni and Fasciola hepatica, as well as the obtainment of new 
cubebin-related semi-synthetic derivatives. 
In addition, our results on the antimicrobial activities of these metabolites also highlighted 
their potential as new antimicrobial agents (Silva et al., 2007; Silva et al., 2009). In this 
context, the literature also reports additional experiments with the objective of investigating 
other features of the antimicrobial activity, such as the time-kill curve experiments based on 
D’Arrigo et al (2010) and investigations about a possible synergistic effect between the most 
effective tested lignans and the current used antimicrobial agents (White et al., 1996).  
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